Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

3 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 4

3(42.9%)

N/A

3(42.9%)

Phase 2

1(14.3%)

7Total

Phase 4(3)

N/A(3)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06943729Recruiting

Clinical Safety and Efficacy of Flow-diverter in the Treatment of Intracranial Aneurysms

Role: collaborator

NCT05286710Not ApplicableRecruiting

Rheolytic Thrombectomy For Acute Deep Vein Thrombosis Of Whole Lower Limb

Role: collaborator

NCT04525729Phase 4Completed

Rituximab and RASi in Patients with IgAN

Role: collaborator

NCT05824390Phase 4Unknown

A Randomized, Controlled Clinical Study of Rituximab in Treatment of Primary IgA Nephropathy

Role: collaborator

NCT04486430Phase 2Completed

Efficacy and Safety Study of Neu2000KWL for Acute Ischemic Stroke Patients Within 6 Hours of Onset

Role: collaborator

NCT03332433Not ApplicableCompleted

High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Gastroscopy Sedated by Propofol

Role: collaborator

NCT02436018Not ApplicableUnknown

WEI NASAL JET for The Sedation of Outpatient Upper Gastrointestinal Endoscopy

Role: collaborator

NCT01979549Unknown

Adverse Events During Upper Gastrointestinal Endoscopy

Role: collaborator

NCT00548223Phase 4Completed

The Secondary Prevention Trial for Ischemic Stroke With DengzhanShengmai Capsule

Role: collaborator

All 9 trials loaded